Arrowsmith et al. reported a neuroprotective effect of this anesthetic during cardiopulmonary bypass CPB, with perioperative application of the NMDA antagonist remacemide, although it was only similar to a secondary endpoint.
Arrowsmith y col. relataron algún efecto neuroprotector de ese anestésico durante el bypass cardiopulmonar CPB con la aplicación perioperatoria del antagonista NMDA remacemide, aunque haya sido solamente parecido con un criterio final de valoración secundario.
Arrowsmith e col. relataram algum efeito neuroprotetor desse anestésico durante bypass cardiopulmonar CPB com a aplicação perioperatória do antagonista NMDA remacemide, embora tenha sido apenas aparente a um endpoint secundário.